← Back to Clinical Trials
Recruiting NCT07454460

NCT07454460 AYA-PeerConnect: A Communication Coaching Intervention for Adolescent/Young Adult Cancer Survivors (AYACS)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07454460
Status Recruiting
Phase
Sponsor Milton S. Hershey Medical Center
Condition Communication
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2026-04-14
Primary Completion 2026-07-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Asynchronous coaching and artificial intelligence (AI) Yoodli coach sessions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2026-04-14 with a primary completion date of 2026-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research is being done to test a communication coaching intervention pilot designed to improve communication quality between adolescent/young adult cancer survivors (AYACS) and their friends/peers. The results of the study will help to understand how to best support adolescent/young adult cancer survivors, and may inform the development or future implementation of similar programs for cancer survivor populations.

Eligibility Criteria

Inclusion Criteria: * Participant is currently ≥18-35 years old * Participant is receiving cancer-directed care at Penn State Cancer Institute or Penn State Children's Hospital * Participant has completed all cancer-directed therapy and is at least 1 year from end of cancer treatment (based on date of last cancer-directed treatment) * Participant has access to a computer with internet capability * Participant is fluent in written and spoken English Exclusion Criteria: * Participant is not fluent in written and spoken English * Participant with cognitive inability to participant in the study as determined by the study team * Participants with history of relapsed cancer

Contact & Investigator

Central Contact

Pooja Rao, MD MSCE

✉ prao2@pennstatehealth.psu.edu

📞 7175316012

Principal Investigator

Pooja Rao, MD MSCE

PRINCIPAL INVESTIGATOR

Penn State College of Medicine

Frequently Asked Questions

Who can join the NCT07454460 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Communication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07454460 currently recruiting?

Yes, NCT07454460 is actively recruiting participants. Contact the research team at prao2@pennstatehealth.psu.edu for enrollment information.

Where is the NCT07454460 trial being conducted?

This trial is being conducted at Hershey, United States.

Who is sponsoring the NCT07454460 clinical trial?

NCT07454460 is sponsored by Milton S. Hershey Medical Center. The principal investigator is Pooja Rao, MD MSCE at Penn State College of Medicine. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology